Recombinant Isfahan Virus Vectored Tri-Valent Vaccine to Protect Against Western, Eastern, and Venezuelan Equine Encephalitis Virus

Project: Other project

StatusFinished
Effective start/end date7/17/1511/3/18

Funding

  • Profectus BioSciences Incorporated: $269,909.57